Unknown

Dataset Information

Genome-wide Mendelian randomization identifies actionable novel drug targets for psychiatric disorders.


ABSTRACT: Psychiatric disorders impose tremendous economic burden on society and are leading causes of disability worldwide. However, only limited drugs are available for psychiatric disorders and the efficacy of most currently used drugs is poor for many patients. To identify novel therapeutic targets for psychiatric disorders, we performed genome-wide Mendelian randomization analyses by integrating brain-derived molecular quantitative trait loci (mRNA expression and protein abundance quantitative trait loci) of 1263 actionable proteins (targeted by approved drugs or drugs in clinical phase of development) and genetic findings from large-scale genome-wide association studies (GWASs). Using transcriptome data, we identified 25 potential drug targets for psychiatric disorders, including 12 genes for

SUBMITTER: Liu J 

PROVIDER: S-EPMC9483418 | biostudies-literature | 2023 Jan

REPOSITORIES: biostudies-literature